Evelyn Pau

Vice President and Recruiting Lead at Bloom Burton & Co.

Evelyn Pau, PhD, is a prominent figure in the healthcare investment banking sector, currently serving as the Vice President and Recruiting Lead at Bloom Burton & Co., a leading life science-focused investment bank in Canada. She has been with the firm since November 2012, initially joining as an Analyst and progressing through various roles to her current position, which she has held since April 2019.1 3 4

Educational Background

Evelyn holds a Doctor of Philosophy (PhD) in Immunology from the University of Toronto, where she specialized in genetics and autoimmunity. She also earned a Bachelor of Medical Sciences from Western University.1 3 4

Professional Experience

At Bloom Burton, her responsibilities encompass:

Monetization Planning: Developing strategies to help clients achieve financial success.
Strategy Consulting: Providing strategic advice to clients in the pharmaceutical and biotechnology sectors.
Scientific and Clinical Due Diligence: Conducting thorough evaluations of scientific and clinical data for investment purposes.
Recruiting and Talent Management: Leading efforts to attract and retain top talent within the firm.2 3

In addition to her role at Bloom Burton, Evelyn has also served as a Guest Lecturer at the University of Toronto's Temerty Faculty of Medicine and has been involved with various initiatives aimed at fostering innovation in healthcare.1 3

Contributions and Impact

Evelyn Pau is recognized for her ability to bridge the gap between academia and industry, leveraging her scientific expertise to inform investment decisions. She has emphasized the importance of understanding market dynamics and commercialization strategies for academic discoveries to succeed in the healthcare sector.2 Her work not only supports emerging technologies but also aims to bring innovative healthcare solutions to market efficiently.

Overall, Evelyn Pau exemplifies a successful integration of scientific knowledge with business acumen, making significant contributions to both her firm and the broader healthcare industry.